Mylan Laboratories Limited Tenofovir Export Data — India (DGFT 2022–2026)

Name: Mylan Laboratories Limited Tenofovir Export Records India — #3 Exporter, 1,002 Shipments, $50.1M FOB USD (DGFT 2022–2026)
Creator: TransData Nexus
Published: 2026-05-01T00:00:00Z
License: https://transdatanexus.com/terms-and-conditions

Suresh Sormare

Tenofovir

India Pharmaceutical Trade Intelligence

$4.3B296 Suppliers182 CountriesHS 30049099

ExportsIndia → BOTSWANA73.3%India → TANZANIA6.1%

ImportsISRAEL → India$20.5M UNITED STATES → India$1.1M

#1 Buyer: AFRICURE PHARMACEUTICALS

Mylan Laboratories Limited — Tenofovir Exporter #3 | $50.1M Trade Value | TransData Nexus | TransData Nexus

Mylan Laboratories Limited — Tenofovir Exporter Profile

Indian Pharmaceutical Exporter · #3 for Tenofovir · $50.1M export value · DGFT Verified

Mylan Laboratories Limited is the #3 Indian exporter of Tenofovir with $50.1M in export value and 1,002 verified shipments. Mylan Laboratories Limited holds a 1.2% market share in Tenofovir exports across 111 countries. The company exports 91 pharmaceutical products worth $634.8M across 26 therapeutic categories.

Mylan Laboratories Limited — Tenofovir Export Profile: Buyers & Destinations

Mylan Laboratories Limited Tenofovir export treemap — buyers and destination countries | TransData Nexus

Where Does Mylan Laboratories Limited Export Tenofovir?

Country	Value	Shipments	Share
SOUTH AFRICA	$5.2M	109	18.4%
KENYA	$1.4M	38	4.8%
THAILAND	$1.3M	39	4.7%
NIGERIA	$1.3M	27	4.5%

Who Are the Top Buyers of Tenofovir from Mylan Laboratories Limited?

Buyer	Country	Value	Orders
VIATRIS HEALTHCARE PTY LTD KEMPTON PARK	SOUTH AFRICA	$1.2M	24
XXGUIXXEM XXOCIXXE GXXNEEXXE DXXPORXXTIOXXET XX	GUINEA	$900.0K	18
USAID THE MISSION DIRECTOR	NIGERIA	$772.0K	16
KENYA MEDICAL SUPPLIES	KENYA	$600.0K	12
CENTRAL PHARMACEUTICAL CPC1. JSC	VIETNAM, DEMOCRATIC REP. OF	$594.2K	12
VIATRIS HEALTHCARE (PTY) LTD,	SOUTH AFRICA	$541.9K	13
EMBASSY OF THE UNITED STATES OF AME	TANZANIA	$513.7K	11
VIATRIS HEALTHCARE PTY LTD	SOUTH AFRICA	$500.0K	10
NATIONAL CENTER FOR HIV/AIDS,	CAMBODIA	$477.1K	13
MINISTERIO DA SAUDE/DEPARTAMENTO DE	BRAZIL	$450.0K	9

Mylan Laboratories Limited supplies Tenofovir to 339 buyers globally. The largest buyer is VIATRIS HEALTHCARE PTY LTD KEMPTON PARK (SOUTH AFRICA), followed by XXGUIXXEM XXOCIXXE GXXNEEXXE DXXPORXXTIOXXET XX (GUINEA) and USAID THE MISSION DIRECTOR (NIGERIA). These buyers represent pharmaceutical distributors, hospital groups, and government procurement agencies in their respective markets.

What Tenofovir Formulations Does Mylan Laboratories Limited Export?

Product Description / Formulation	Value	Shipments
TENOFOVIRDISOPROXILFUMARATE300MG+	$2.2M	47
ACRIPTEGA TENOFOVIRDISOPROXILFUMARATE	$2.2M	45
TENOFOVIR DISOPROXIL FUMARATE 300MG + LA	$1.2M	44
TENOFOVIR DISOPROXIL FUMARATE 300 MG+ EM	$912.2K	29
TENOFOVIR DISOPROXIL FUMARATE300 MG TABL	$536.1K	34
TENOFOVIR DISOPROXIL FUMARATE 300MG + EM	$521.9K	14
Tenofovir Disoproxil Fumarate 300Mg+ Emt	$439.1K	10
TENOFOVIR DISOPROXIL FUMARATE 300 MG+EMT	$383.5K	11
TENOFOVIR DISOPROXIL FUMARATE 300 MG + E	$341.6K	16
TENOFOVIR DISOPROXIL FUMARATE 300MG TABL	$335.4K	12

Mylan Laboratories Limited exports 470 distinct Tenofovir formulations including tablets, capsules, syrups, and combination drugs. The top formulation is TENOFOVIRDISOPROXILFUMARATE300MG+ with 47 shipments worth $2.2M.

How Does Mylan Laboratories Limited Compare to Nearest Tenofovir Exporters?

Exporters ranked immediately above and below #3 by export value

#	Supplier	Export Value	Shipments	Countries	Avg/Shipment
2	HETERO LABS LIMITED	$64.3M	1,285	105	$50.0K
3	MYLAN LABORATORIES LIMITED ★	$50.1M	1,002	111	$50.0K
6	CIPLA LIMITED	$40.4M	808	44	$50.0K
1	MACLEODS PHARMACEUTICALS LTD	$25.9M	519	74	$50.0K

Mylan Laboratories Limited ranks #3 among 296 Indian Tenofovir exporters. Average shipment value of $50.0K compared to the market average of $767.2K. The closest competitors by value are HETERO LABS LIMITED and CIPLA LIMITED.

Which Indian Ports Ship Tenofovir Exports?

Port	Shipments	% Share
SAHAR AIR	1,351	18.0%
SAHAR AIR CARGO ACC (INBOM4)	1,121	14.9%
NHAVA SHEVA SEA (INNSA1)	526	7.0%
DELHI AIR CARGO ACC (INDEL4)	463	6.2%
HYDERABAD AIR	453	6.0%
DELHI AIR	433	5.8%
Bombay Air	371	4.9%
HYDERABAD ACC (INHYD4)	351	4.7%

Geopolitical & Trade Policy Impact on Mylan Laboratories Limited's Tenofovir Exports

Mylan's export operations are influenced by a complex geopolitical landscape. The Israel-Iran tensions have led to disruptions in Red Sea shipping routes, resulting in increased freight costs and extended transit times. Major shipping lines have implemented 'Emergency Risk Surcharges' ranging from $250 to $500 per TEU, directly impacting the cost structure for Indian pharmaceutical exporters like Mylan. Additionally, diversions around the Cape of Good Hope have further elongated delivery schedules, posing challenges to time-sensitive pharmaceutical shipments.

In the United States, the imposition of tariffs on pharmaceutical imports has prompted Indian companies to reassess their market strategies. While generics have largely remained exempt, the potential for future tariff expansions necessitates vigilance. Mylan, along with other Indian exporters, is exploring market diversification to mitigate reliance on the U.S. market. The recent India-European Union Free Trade Agreement (FTA), signed in January 2026, offers a strategic avenue for expansion. The FTA eliminates tariffs on approximately 97% of EU tariff lines, including pharmaceuticals, thereby enhancing market access for Indian exporters. This agreement is expected to significantly boost India's pharmaceutical exports to Europe, providing a counterbalance to uncertainties in the U.S. market.

Mylan Laboratories Limited — Regulatory Compliance & Quality Standards

Compliance with international regulatory standards remains paramount for Mylan. The FDA's warning letter and import alert in December 2024 concerning the Indore facility underscore the critical importance of stringent quality control measures. The cited violations, including subpar quality control and improper management of manufacturing defects, have necessitated comprehensive corrective actions. Mylan's proactive response aims to restore compliance and reinforce its commitment to quality assurance.

The evolving regulatory environment, particularly in the European Union, further emphasizes the need for adherence to Good Manufacturing Practices (GMP). The EU's Falsified Medicines Directive mandates rigorous compliance to ensure product integrity and patient safety. For Mylan, aligning with these standards is essential to maintain and expand its foothold in the European market.

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Analysis Methodology

1.Product Matching: Tenofovir shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature.
2.Supplier Identification: Mylan Laboratories Limited matched across shipments using name normalization, accounting for company name formatting variations.
3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort company rankings.
4.Verified Records: This page is backed by 1,002 individual customs records matching Mylan Laboratories Limited exporting Tenofovir, covering 470 formulations to 119 countries via 339 buyers.

Government-Sourced Data

Official DGFT customs records

Transparent Methodology

Calculations fully disclosed above

Global Coverage

Exports to 182+ countries, 1,436+ buyers

Expert-Reviewed

Analyzed by pharmaceutical trade specialists

Tenofovir

Tenofovir

Mylan Laboratories Limited — Tenofovir Exporter Profile

Mylan Laboratories Limited — Tenofovir Export Profile: Buyers & Destinations

Where Does Mylan Laboratories Limited Export Tenofovir?

Who Are the Top Buyers of Tenofovir from Mylan Laboratories Limited?

What Is India's Total Tenofovir Export Value and How Much Does Mylan Laboratories Limited Contribute?

What Is the Average Shipment Value for Mylan Laboratories Limited's Tenofovir Exports?

How Does Mylan Laboratories Limited Compare to Other Indian Tenofovir Exporters?

What Tenofovir Formulations Does Mylan Laboratories Limited Export?

Regulatory Requirements: Exporting Tenofovir to Key Markets

South Africa — SAHPRA

How Does Mylan Laboratories Limited Compare to Nearest Tenofovir Exporters?

Which Indian Ports Ship Tenofovir Exports?

What Other Antiviral & HIV Medications Products Does Mylan Laboratories Limited Export?

Tenofovir — Export Intelligence Video

Geopolitical & Trade Policy Impact on Mylan Laboratories Limited's Tenofovir Exports

Mylan Laboratories Limited — Regulatory Compliance & Quality Standards

About Mylan Laboratories Limited

Market Intelligence

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Primary Data Source

Analysis Methodology

Get Tenofovir Export Data from Mylan Laboratories Limited

Tenofovir Stats

Company Overview

Top Products by Mylan Laboratories Limited

Related Analysis

Need Detailed Export Data?

Data Source